20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
A COMPOSITION, A KIT AND USE THEREOF
#902BENZOAZEPINE COMPOUND-CONTAINING FREEZE-DRIED COMPOSITION
#903Parenteral esmolol formulation
#904Method for freeze-drying cells in a hydrogel comprising nanofibrillar cellulose and freeze-dried cells in an aerogel comprising nanofibrillar cellulose
#905AGONIST OF SPEXIN-BASED GALANIN TYPE 2 RECEPTOR AND USE THEREOF
#906FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS
#907Cariprazine release formulations
#908Improved Lyophilized Formulations Involving Hyaluronic Acid and Plasmatic Proteins, and Uses Thereof
#909Masked Antibody Formulations
#910Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#911THE USE OF LOW MOLECULAR WEIGHT POLYVINYLPYRROLIDONE (PVP) TO REDUCE VISCOSITY OF HIGH CONCENTRATION PROTEIN FORMULATIONS
#912PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2
#913FORMULATIONS OF FOSAPREPITANT AND APREPITANT
#914COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY
#915Storage stable sincalide formulations
#916Injectable composition containing prodrug of caspase inhibitors, and preparation method therefor
#917COMPOSITIONS COMPRISING BACTERIAL STRAINS
#918ANTI-CD19 ANTIBODY FORMULATIONS
#919CURCUMIN COMPOUND COMPOSITION AND METHOD FOR PREPARAING SAME
#920Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
#921MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES
#922DRY MICROPARTICLES
#923Honokiol crystal forms, amorphous form and preparation thereof
#924EFFECT OF COMBINATION OF BIFIDOBACTERIUM AND BERBERINE ON PRE-DIABETES AND TYPE 2 DIABETES
#925VIABLE LYOPHILIZED COMPOSITIONS DERIVED FROM HUMAN TISSUES AND METHODS OF MAKING THE SAME
#926Freeze-dried product and gas-filled microvesicles suspension
#927Cleavable lipids
#928Novel Method for Obtaining Efficient Viral Vector-Based Compositions for Vaccination or Gene Therapy
#929LYOPHILIZED VIRUS FORMULATIONS
#930WASHED PLATELET EXTRACT
#931METHOD FOR PREPARING STABLE PEPTIDE FORMULATIONS
#932PHARMACEUTICAL COMPOSITIONS COMPRISING OTIC THERAPEUTIC AGENTS AND RELATED METHODS
#933Anti-IL-31RA antibody-containing formulations
#934THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY
#935FREEZE-DRIED FORMULATION, PREPARATION METHOD AND APPLICATION THEREOF
#936SPRAY-DRIED FORMULATION OF A PYRIDAZINONE TRPC5 INHIBITOR
#937CARRIER-BINDING AGENT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#938High concentration formulations of anti-CSF1 and anti-CSF1R antibodies
#939POWDER FORMULATION FOR INTRANASAL ADMINISTRATION, AND MANUFACTURING METHOD THEREOF
#940Sulfoximine glycosidase inhibitors
#941FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
#942Compositions, methods and uses for thermally stable multi-targeted antigens
#943Chloride salt of TAT-NR2B9C
#944Pairing probiotics and prebiotics, methods for growth and use, separately and in combination
#945FORMULATIONS FOR ENCAPSULATION AND BIOAVAILABILITY IMPROVEMENT OF BIOACTIVE COMPOUNDS BASED ON NATURAL PLANT BASED MATERIALS
#9466-pyrimidin-isoindole derivative as ERK1/2 inhibitor
#947Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfaces
#948PREPARATION OF SOLUBLE FORM OF CURCUMIN
#949Dry powder composition comprising long-chain RNA
#950Therapeutic agent for disc herniation
#951Use of c-type natriuretic peptide variants to treat osteoarthritis
#952METHOD FOR PRODUCING SPIRULINA EXTRACT, AND SPIRULINA EXTRACT-CONTAINING PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR IMPROVING COGNITIVE ABILITY
#953Lyophilization of RNA
#954Lyophilized formulations of tegavivint
#955Lyophilized formulations of tegavivint
#956Lyophilized formulations of tegavivint
#957BROAD-BASED THERAPEUTIC FOR INACTIVATING COVID-19 AND OTHER VIRAL PATHOGENS USING CHEMILUMINESCENCE-ACTIVATED COMPOUNDS ENCAPSULATED IN NANOPARTICLES
#958PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF
#959Vaccine delivery systems using yeast cell wall particles
#960USE OF AMINO ACID BASED NUTRIENTS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
#961Rapidly infusing platform and compositions for therapeutic treatment in humans
#962FREEZE-DRIED POLYMER COMPOSITIONS FOR MIXING WITH PLATELET RICH PLASMA TO FORM IMPLANTS FOR TISSUE REPAIR AND/OR COMPOSITIONS FOR THERAPEUTIC INTRA-ARTICULAR INJECTIONS
#963PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
#964Adeno-Associated Virus Vector Formulations and Methods
#965ACTIVE SUBSTANCE OF LACTOBACILLUS PLANTARUM GKM3, A COMPOSITION COMPRISING THEREOF AND ITS USE FOR PROMOTING LONGEVITY
#966Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
#967NON-STEROIDAL ANTI-INFLAMMATORY LYOPHILIZED PHARMACEUTICAL COMPOSITION
#968TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR
#969TREATMENT OF SANFILIPPO SYNDROME TYPE B
#970Methods and compositions for CNS delivery of heparan N-sulfatase
#971METHOD FOR HYDRATING LYOPHILIZED CYCLOPHOSPHAMIDE COMPOSITION AND PRODUCT THEREOF
#972Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions
#973Solid Δ-tetrahydrocannabinol (Δ-THC) compositions
#974PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION
#975P-ethoxy nucleic acids for STAT3 inhibition
#976COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS
#977Methods of administering anti-IL31A antibody-containing formulations
#978AQUEOUS FORMULATIONS OF WATER INSOLUBLE COX-2 INHIBITORS
#979Chondroitin sulfate glycosaminoglycan hydrogel matrices for the treatment of traumatic brain injury
#980METHOD AND DEVICE FOR TREATING PARTICLES AND NANOPARTICLES OF AN ACTIVE PHARMACEUTICAL INGREDIENT
#981ALBUMIN NANOPARTICLES, THE MAKING METHOD, AND USES THEREOF
#982Dry Pharmaceutical Formulations of CNP Conjugates
#983USE OF MORCHELLA ACTIVE SUBSTANCE
#984Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
#985ANTIBODY FORMULATIONS
#986ANTIBODY FORMULATIONS
#987SYSTEM FOR LYOPHILIZING, RECONSTITUTING, AND DELIVERING A MEDICATION, AND RELATED METHODS
#988Preparation of preliposomal Annamycin lyophilizate
#989Thrombin solution and methods of use thereof
#990SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF
#991COMPOSITIONS COMPRISING BACTERIAL STRAINS
#992WATER-BASED ANTIFUNGAL COMPOSITIONS
#993PHARMACEUTICAL COMPOSITIONS FOR SUBCUTANEOUS ADMINISTRATION OF LEVOSIMENDAN
#994LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER
#995FORMULATIONS OF MONOCLONAL ANTIBODIES
#996VISCOSITY REDUCTION OF HIGHLY CONCENTRATED PROTEIN FORMULATIONS
#997PHARMACEUTICAL PREPARATION FOR TREATING HEPATITIS B, PREPARATION METHOD THEREFOR AND USE THEREOF
#998COMPOSITIONS AND METHODS FOR INCREASING THE VIABILITY OF FREEZE-DRIED PROBIOTICS
#999COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1000Methods for treatment of diseases
#1001USE OF AMINO ACIDS AS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS
#1002STABLE DRY POWDER COMPOSITION COMPRISING BIOLOGICALLY ACTIVE MICROORGANISMS AND/OR BIOACTIVE MATERIALS AND METHODS OF MAKING
#1003A LYOPHILIZED COMPOSITION OF PEGASPARGASE
#1004Subcutaneous administration of ADAMTS13
#1005Continuous roll-to-roll freeze-drying system and process
#1006RECOMBINANT CLUSTERIN AND USE THEREOF IN THE TREATMENT AND PREVENTION OF DISEASE
#1007PROTEIN BASED EXCIPIENT FOR ACTIVE PHARMACEUTICAL INGREDIENTS
#1008PREPARATION INCLUDING VACCINE ADJUVANT
#1009METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION
#1010Polymer particles for neutrophil injury
#1011Recombinant Glycoproteins and Uses Thereof
#1012USE OF THIOSULFATE TO POTENTIATE THE ANTI-PATHOGENIC EFFECT OF LACTOBACILLI
#1013DIHYDROMYRICETIN SPRAY-DRIED DISPENSION FORMULATIONS AND METHODS FOR FORMING THEM
#1014Compositions and methods for lyophilization of bacteria or listeria strains
#1015Lyophilization systems and methods
#1016POWDER, WOUND-COVERING MATERIAL, ADHESION PREVENTION MATERIAL, HEMOSTATIC MATERIAL, AND PRODUCTION METHOD FOR POWDER
#1017Solid forms of ceftolozane and processes for preparing
#1018TERNARY MICELLAR COMPLEX COMPOSED OF A SIALOGLYCOSPHINGOLIPID, A THERAPEUTICALLY ACTIVE SUBSTANCE AND AN ANTIBODY
#1019Stabilised Compositions of Factor VII Polypeptides
#1020COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALLERGY
#1021ENHANCED OSTEOGENIC COMPOSITION
#1022Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
#1023TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION
#1024Method for making reduction sensitive nano micelles
#1025PHARMACEUTICAL COMPOSITIONS COMPRISING PEPTIDE VARIANTS AND METHODS OF USE THEREOF
#1026Method of lyophilizing lipid nanoparticles
#1027Polycarbonate containing compounds and methods related thereto
#1028HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY-CONTAINING PHARMACEUTICAL COMPOSITION
#1029Angiopoietin 2, VEGF dual antagonists
#1030Reagents and methods for cancer treatment using Magnetic particle
#1031COMPOSITIONS AND METHODS FOR TRANSFECTING CELLS
#1032Rabies composition comprising PIKA adjuvant
#1033PROBIOTICS FOR COGNITIVE AND MENTAL HEALTH
#1034COMPOSITIONS COMPRISING SHORT-ACTING BENZODIAZEPINES
#1035Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128
#1036ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
#1037Stabilized Formulations Containing Anti-CTLA-4 Antibodies
#1038Methods and compositions for treating ulcerative colitis
#1039MICROENCAPSULATED AND CHROMOSOME INTEGRATED COMPOSITIONS FOR L-DOPA MICROBIOME THERAPY
#1040COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1041Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
#1042Process for lyophilising a product
#1043Lyophilisate of treosulfan
#1044DRUG COMPOUND AND PURIFICATION METHODS THEREOF
#1045Pharmaceutical composition comprising anti-human TSLP receptor antibody
#1046Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds
#1047Lyophilized preparation of prostaglandin E1 methyl ester for injection and production and use thereof
#1048Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3
#1049LYOPHILIZED PHARMACEUTICAL COMPOSITIONS
#1050METHODS OF TREATING OR PREVENTING STENT THROMBOSIS
#1051PEPTIDE CONJUGATED PARTICLES
#1052COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1053Preparation and application of grain worm for treating diabetes
#1054PHARMACEUTICAL COMPOSITION FOR TREATING WOUNDS
#1055Dilutable formulations of cannabinoids and processes for their preparation
#1056FREEZE-DRIED ARIPIPRAZOLE FORMULATION
#1057Process for extracting substances of interest
#1058TACI-FC FUSION PROTEINS AND USES THEREOF
#1059Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
#1060Peptide conjugated particles
#1061GLP1-FC FUSION PROTEIN AND CONJUGATE THEREOF
#1062Compositions for fecal floral transplantation and methods for making and using them and device for delivering them
#1063Natural killer cell containing exogenous mitochondrium and pharmaceutical composition comprising same
#1064PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR
#1065Albumin pharmaceutical composition and preparation method therefor
#1066Antibodies to symmetrically dimethylated arginine analytes and use thereof
#1067STABLE FORMULATIONS OF THERAPEUTIC ANTIBODY
#1068Treatment of tobacco addiction by a tobacco leaf extract
#1069Polymer particles
#1070DEVICES FOR RECONSTITUTING AND DELIVERING LYOPHILIZED DRUGS
#1071VEGF Antagonist Formulations
#1072SILICA-BASED DRUG NANOCAPSULES
#1073VEGF Antagonist Formulations
#1074DOCETAXEL COMPOSITION FOR INJECTION AND PREPARATION METHOD THEREFOR
#1075Probiotic skin formulations
#1076Site-specific conjugation of linker drugs to antibodies and resulting ADCs
#1077Morphic forms of trilaciclib and methods of manufacture thereof
#1078Crystalline form of treosulfan
#1079Filterable duocarmycin-containing antibody-drug conjugate compositions and related methods
#1080Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
#1081BIOENGINEERED LACTOBACILLUS PROBIOTICS AND THE USES THEREOF
#1082Swine origin probiotics that promote health and growth performance in pigs
#1083METHODS OF CELLULAR REPROGRAMMING
#1084Peptides for inducing heterosubtypic influenza T cell responses
#1085METHOD FOR PREPARING AND DELIVERING BISANTRENE FORMULATIONS
#1086IL-2 FUSION POLYPEPTIDE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#1087NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#1088Curcumin nanoparticle and preparation and application thereof
#1089Protease Inhibitor-Containing Compositions, Compositions Comprising Same, and Methods for Producing and Using Same
#1090Lyophilized mesenchymal stem cell derived secretome and uses thereof
#1091Process for lyophilized pharmaceutical formulations of a therapeutic protein
#1092Pharmaceutical compositions of sulfur colloid and processes thereof
#1093METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION
#1094CARMUSTINE FORMULATION
#1095Storage stable sincalide formulations
#1096Thermostable vaccine compositions and methods of preparing same
#1097Methods of treating severe inflammation
#1098Compositions and methods for stabilizing protein-containing formulations
#1099Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#1100BLOOD PLASMA-CONTAINING COMPOSITIONS
#1101NANOPARTICLE/HYDROGEL COMPLEXT FOR DRUG CARRIER
#1102Animal protein-free pharmaceutical compositions
#1103TREATMENT OF ANEMIA DUE TO VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES IN SUBJECTS WITH RING SIDEROBLASTS USING ACTIVIN-ACTRll LIGAND TRAPS
#1104PHARMACEUTICAL COMPOSITION COMPRISING PURPLE CORN EXTRACT FOR PREVENTION OR TREATMENT OF SKIN DISEASE
#1105EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#1106BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#1107VEGF antagonist formulations suitable for intravitreal administration
#1108Hydrogel Compositions
#1109COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1110COMPOSITIONS OF SURFACE-MODIFIED THERAPEUTICALLY ACTIVE PARTICLES BY ULTRA-RAPID FREEZING
#1111CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD
#1112LYOPHILIZED PREPARATION OF BPA AND PREPARATION METHOD
#1113INJECTABLE COMPOSITION
#1114STABLE LYOPHILIZED DOSAGE FORM OF PROTEIN
#1115Polysaccharide and methods
#1116Albumin-free botulinum toxin formulations
#1117Self-assembling oxygen carrier compositions
#1118POLYPEPTIDE THERAPEUTICS AND USES THEREOF
#1119High potency stable formulations of vaginal lactobacillus
#1120COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1121Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
#1122Active ingredient consisting of a mixture of polylysine compounds and use in the prevention of strokes and the treatment of the post-stroke inflammatory phase
#1123Animal protein-free pharmaceutical compositions
#1124LIQUID PHARMACEUTICAL COMPOSITION
#1125Anti-IL31RA antibody-containing formulations
#1126Method of producing pharmaceutical compositions comprising immunogenic Chikungunya virus CHIKV-Delta5nsP3
#1127Pharmaceutical composition and preparation method thereof
#1128Methods of treating epithelioid cell tumors
#1129Compositions and Methods for the Treatment of Metabolic Conditions
#1130NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
#1131Lyophilized recombinant VWF formulations
#1132FORMULATIONS FOR IMPROVED STABILITY OF RECOMBINANT HUMAN PARATHYROID HORMONE
#1133STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS
#1134Compositions comprising a bacterial strain of the genus and uses thereof
#1135Treatment of von Willebrand disease
#1136Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
#1137Stable liquid pharmaceutical preparation
#1138GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#1139LIQUID PHARMACEUTICAL COMPOSITION
#1140Lyophilized recombinant VWF formulations
#1141PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
#1142Active substance of , its use and a composition thereof for improving the reproductive function
#1143Pharmaceutical composition comprising cyclodextrin complexes of anethole trithione or derivatives thereof
#1144Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
#1145PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
#1146METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS
#1147Lipid nanoparticle compositions and methods for mRNA delivery
#1148NANOPARTICLE COMPOSITIONS
#1149ULTRASOUND MEDIATED DELIVERY OF DRUGS
#1150Immunogenic composition forming a SARS-CoV-2 vaccine, and a method for its manufacture
#1151STABLE FORMULATIONS OF CYTOMEGALOVIRUS
#1152COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1153Process for preparing microparticles containing glatiramer acetate
#1154Method of preparing degradable and environment responsive composite microgels
#1155SYNP162, a promoter for the expression of genes
#1156NOVEL STABLE HIGH-CONCENTRATION FORMULATION FOR ANTI-FXIa ANTIBODIES
#1157NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#1158THERAPEUTIC LUNG REPAIR BY INHALATION OF LUNG SPHEROID CELL-SECRETED FACTORS
#1159Compositions and methods for treating diverticulitis and related disorders
#1160METHOD FOR THE PRODUCTION OF FREEZE-DRIED PELLETS COMPRISING AN ANTI-COAGULATION FACTOR XIa (FXIa) ANTIBODY
#1161FORMULATIONS OF ANTIBODY
#1162LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
#1163Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines
#1164Compositions and methods of treatment with amniotic fluid
#1165Engineered Exosomes for Medical Applications
#1166Biologic preserving composition and methods of use
#1167METHOD FOR PRODUCING SUSTAINED-RELEASE DRUG, AND SUSTAINED-RELEASE DRUG
#1168Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof
#1169COMPOSITIONS COMPRISING BACTERIAL STRAINS
#1170Method of treating a bacterial infection using colostrum
#1171METHOD OF TREATING A BACTERIAL INFECTION USING COLOSTRUM
#1172Bactericidal and virucidal pharmaceutical composition
#1173EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#1174Anti-BAFFR antibody formulations and methods of use thereof
#1175Animal protein-free pharmaceutical compositions
#1176Heroin vaccine
#1177Pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
#1178MODIFIED ANTIBODY-ALBUMIN NANOPARTICLE COMPLEXES FOR CANCER TREATMENT
#1179FORMULATIONS FOR TREATING BLADDER CANCER
#1180ANTI-TIM3 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF
#1181Compositions for treatment of disorders
#1182PHARMACEUTICAL COMPOSITION CONTAINING ILAPRAZOLE OR SALT THEREOF AND PREPARATION METHOD THEREFOR
#1183METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY
#1184Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
#1185USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA
#1186Organosilanes for the treatment of infections
#1187Compositions and methods for the diagnosis, treatment and prevention of neoplastic and neurological disorders
#1188VEGF Antagonist Formulations
#1189Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
#1190SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF GLAUCOMA
#1191Nanoparticles containing a taxane and their use
#1192LIPID NANOPARTICLE MRNA VACCINES
#1193Compositions and methods for treating Pompe disease
#1194Enzymes Entrapped in Organopolysiloxane Matrix for Treating Intestinal Diseases
#1195FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY
#1196PHARMACEUTICAL COMPOSITIONS IN LYOPHILIZED FORM
#1197Lyophilization process and a teverelix-TFA lyophilizate obtained thereby
#1198Target residual moisture content for lyophilized drug product
#1199Method of managing joint pain
#1200Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres